Rapid weight loss associated with GLP-1 medications can reduce facial fat pads and collagen, leaving some patients with a hollowed, gaunt or sagging appearance
Individuals with type 2 diabetes and those struggling with obesity may consider using Tirzepatide to manage their conditions effectively
The process may involve: Consultation with Healthcare Provider : Discussing reasons for switching, reviewing medical history, and assessing suitability for tirzepatide
Share: People taking GLP-1 medications for type 2 diabetes (liraglutide, semaglutide, or tirzepatide) may be more likely to stop and later restart treatment than many people realize, according to research presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill
Delaying or advancing injections by one or two days does not significantly alter efficacy if timing is normalized
Disclose any allergies, medications, or health concerns